Back
ESC Professional Premium Access

Long-term outcome and mortality predictors in patients with extremely enlarged left ventricle end-diastolic diameter undergoing cardiac resynchronization therapy

Session: Chronic heart failure - ICD, device and cardiac resynchronisation therapy
Topic: Cardiac Resynchronisation Therapy (CRT)
Speaker: Associate Professor M. Mazurek (Zabrze, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Michal Mazurek

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
1 follower

6 more presentations in this session

Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction

Speaker: Associate Professor T. Cinar (Istanbul, TR)

Access
Abstract
Slides
Like
Thumbnail

Novel clinical data on cardiac contractility modulation in NYHA II patients - Results from the MAINTAINED Observational Study

Speaker: Doctor C. Fastner (Mannheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Fusion CRT pacing: septal flash significance in super responder patients

Speaker: Doctor C. Vacarescu (Timisoara, RO) Doctor S. Crisan (Timisoara, RO)

Access
Abstract
Slides
Like
Thumbnail

Clinical implications and risk factors for QRS width progression in heart failure patients

Speaker: Doctor M. Berger (Aachen, DE)

Access
Abstract
Slides
Like
Thumbnail

Lower rate limit in cardiac resynchronization therapy defibrillators

Speaker: Doctor M. Barradas (Ponta Delgada, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Chronic heart failure - ICD, device and cardiac resynchronisation therapy

Speakers: Associate Professor M. Mazurek, Associate Professor T. Cinar, Doctor C. Fastner, Doctor C. Vacarescu, Doctor S. Crisan...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources